StonvexLoading…
StonvexStonvexStonvexCore line items from ANNA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $9.34M | $25.04M | $15.90M | $4.68M |
Operating Income | $3.70M | $2.90M | $2.69M | $-3.04M |
Net Income | $2.07M | $2.88M | $2.62M | $-2.69M |
EPS (Diluted) | $0.05 | $0.04 | $0.04 | $-0.04 |
Total Assets | $101.36M | $101.30M | $100.06M | $89.85M |
Total Liabilities | $40.65M | $42.62M | $41.73M | $37.55M |
Cash & Equivalents | $31.12M | $31.83M | $31.20M | $23.98M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 40.66M | 40.63M | 40.63M | 40.60M |